For TIMP-2, the included studies typically reported a reduction in expression in PrCa [55,83,112,182,188], including a negative correlation of the expression to tumor grade [105,146] and metastasis [146], with promoter hypermethylation representing one mechanism by which the expression could be lost [188]. The gene discussed is TIMP2; the disease is neoplasm.